Russell Investments Group, Ltd. - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 63 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$21,000
-50.0%
8,421
-10.5%
0.00%
Q1 2022$42,000
-78.0%
9,407
-66.6%
0.00%
Q4 2021$191,000
-30.3%
28,178
-25.2%
0.00%
Q3 2021$274,000
-29.9%
37,662
-3.7%
0.00%
-100.0%
Q2 2021$391,000
+171.5%
39,127
+157.6%
0.00%
Q1 2021$144,00015,1880.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 2,945,948$5,184,8681.60%
Aisling Capital Management LP 1,043,267$1,836,1500.90%
Knott David M Jr 140,921$2480.10%
XTX Topco Ltd 233,493$410,9480.07%
Pentwater Capital Management LP 5,975,000$10,516,0000.07%
Atom Investors LP 49,413$86,9670.03%
EcoR1 Capital, LLC 676,296$1,190,2810.03%
Forefront Analytics, LLC 26,619$46,8500.03%
FNY Investment Advisers, LLC 11,500$200.02%
CORNERCAP INVESTMENT COUNSEL INC 80,979$142,5230.02%
View complete list of POSEIDA THERAPEUTICS INC shareholders